T A Standaert
Overview
Explore the profile of T A Standaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Standaert T, Truog W, Guthrie R, Murphy J, LaFramboise W, Palmer S, et al.
Am J Primatol
. 2020 Mar;
7(2):107-119.
PMID: 32131567
Growth and development of the infant pigtailed macaque (Macaca nemestrina) over the first 3 weeks of life have been characterized by the variables of body weight, blood pressure, heart rate,...
2.
Tiddens H, Geller D, Challoner P, Speirs R, Kesser K, Overbeek S, et al.
J Aerosol Med
. 2007 Jan;
19(4):456-65.
PMID: 17196074
Several inhaled drugs for use by cystic fibrosis (CF) patients are formulated for nebulizer use only. This therapy is time consuming and includes the risk of contamination of the nebulizers....
3.
Standaert T, Bohn S, Aitken M, Ramsey B
J Aerosol Med
. 2001 Aug;
14(1):31-42.
PMID: 11495483
Manufacturers of aerosolized medications, approved by the Food and Drug Administration, specify the nebulizer(s) and compressor to be used with their product, in an attempt to achieve efficacy comparable to...
4.
Standaert T, VanDevanter D, Ramsey B, Vasiljev M, Nardella P, Gmur D, et al.
J Aerosol Med
. 2000 Sep;
13(2):147-53.
PMID: 11010595
Recent U.S. Phase III trials of the aerosolized delivery of tobramycin to cystic fibrosis (CF) patients demonstrated a significant improvement in pulmonary function and in sputum bacterial density. These trials...
5.
Mayock D, Standaert T, Watchko J, Woodrum D
Pediatr Pulmonol
. 1998 Dec;
26(5):312-8.
PMID: 9859899
Previous investigations have shown that ventilatory failure during severe inspiratory resistive loading (IRL) in the 21-day-old infant primate occurs secondary to a decrease in respiratory frequency, that is, central failure....
6.
Halbert C, Standaert T, Wilson C, Miller A
J Virol
. 1998 Nov;
72(12):9795-805.
PMID: 9811715
The airway is an important target for gene transfer to treat cystic fibrosis and other diseases that affect the lung. We previously found that marker gene expression did not persist...
7.
Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation
Standaert T, Morlin G, Joy P, Pepe M, Weber A, Ramsey B
Chest
. 1998 Sep;
114(2):577-86.
PMID: 9726748
Study Objective: Patients with cystic fibrosis use disposable jet nebulizers for the self-administration of antibiotics, DNase, and bronchodilators several times per day. Most patients elect to reuse their disposable nebulizers....
8.
Tarczy-Hornoch P, Hildebrandt J, Standaert T, Jackson J
J Appl Physiol (1985)
. 1998 May;
84(4):1316-22.
PMID: 9516199
Treatments available to improve compliance in surfactant-deficient states include exogenous surfactant (ES) and either partial (PLV) or total liquid ventilation (TLV) with perfluorochemical (PFC). Because of the additional air-lung and...
9.
Rosenfeld M, Emerson J, Astley S, Joy P, Standaert T, Yim D, et al.
J Pediatr
. 1998 Feb;
132(1):125-31.
PMID: 9470013
Objective: To describe current patterns of home nebulizer use among patients with cystic fibrosis. Study Design: A population-based survey of home nebulizer practices among 227 patients with cystic fibrosis using...
10.
Halbert C, Standaert T, Aitken M, Alexander I, Russell D, Miller A
J Virol
. 1997 Aug;
71(8):5932-41.
PMID: 9223483
The ability of recombinant adeno-associated virus (AAV) vectors to integrate into the host genome and to transduce nondividing cells makes them attractive as vehicles for gene delivery. In this study,...